Immune System Diseases and Dermatology

At Suomen Terveystalo Oy in Helsinki, clinical research in immune system diseases focuses mainly on atopic dermatitis and atopic dermatitis (AD). These studies are designed to assess new treatment options and better understand how well emerging therapies work for people with moderate-to-severe disease.

  • Evaluating the effectiveness of rocatinlimab for atopic dermatitis
  • Studying safety and tolerability in adolescents with moderate-to-severe AD
  • Comparing treatment outcomes against placebo using clinical skin assessments

This area of research helps clarify how new dermatology treatments may improve symptom control and disease management for patients.

Respiratory Tract Diseases

Research in respiratory tract diseases at this site includes studies in chronic obstructive pulmonary disease (COPD). The trials are focused on understanding whether new therapies can reduce flare-ups and support longer-term disease control in people with a history of exacerbations.

  • Assessing the added benefit of tozorakimab alongside standard care
  • Measuring the impact on severe COPD exacerbations
  • Exploring long-term safety and effectiveness in former smokers

This work supports efforts to improve treatment strategies for chronic lung disease and daily breathing health.

Nervous System Diseases and Sleep Medicine

The site also contributes to research in nervous system diseases through studies of insomnia disorder. These trials aim to evaluate whether new treatments can improve sleep quality and provide better options for people living with persistent sleep problems.

  • Testing the effectiveness of tasipimidine for insomnia disorder
  • Focusing on symptom relief and sleep improvement
  • Supporting development of more effective sleep disorder therapies

This research reflects a broader interest in conditions affecting the nervous system and everyday well-being.